Media & Press Updates
Included are selected press releases announcing patent grants for OcuSurf and NanoM technologies.
SELECTED PRESS RELEASES
Hong Kong Grants Patent for Integral BioSystems NanoM™
Japan Grants Patent for Integral BioSystems NanoM™
NanoM™ European Patent Validated in Great Britain, France, Germany, Spain, and Italy
Integral BioSystems and Nacuity Pharmaceuticals Ink NanoM™ Collaboration and License Deal
Integral BioSystems CEO Shikha Barman Featured in Webinar at Virtual ARVO 2021
Integral BioSystems Receives EPO Patent for NanoM™ Drug Formulation Technology
Integral BioSystems Receives Singaporean Patent for NanoM™ Drug Formulation Technology
Specialty Drug Delivery Firm Integral BioSystems LLC Aims to Advance Eyedrop Technology with OcuSurf™ formulation platform
Integral BioSystems Announces Australian Patent Grant on OcuSurf™ Innovation
​Integral BioSystems Receives USPTO Patent for NanoM™ Drug Formulation Technology
Integral BioSystems Receives South African Letters Patent for Drug Formulation Technology
Integral BioSystems LLC Receives Australian Patent for NanoM™ Drug Formulation Technology
Integral BioSystems Announces the Chinese and New Zealand Patents on OcuSurf™ Innovation
Integral BioSystems Announces Chinese Patent for OcuSurf™ Innovation
Integral BioSystems Receives Divisional Patent from USPTO for NanoM™ sustained release technology
Integral BioSystems Announces New Zealand Patent for OcuSurf™ development platform
Integral BioSystems Announces Japanese Patent Grant on OcuSurf™ Innovation